title: Pioneering the trail of cancer immunotherapy.
abstract: The annual conference of the International Society for Biological Therapy of Cancer (iSBTc), recently renamed the Society for Immunotherapy of Cancer (SITC), provides clinicians and scientists with a uniquely broad yet focused view of the growing field of tumor immunology and cancer immunotherapy. In this time of exciting new developments in cancer immunotherapy, it is critically important to effectively guide new immune-based advances from bench to bedside to improve outcomes of patients with cancer. iSBTc/SITC with its dedicated leadership (past and present) provides this guidance through its Annual Meeting and associated programs. This year the society celebrated its 25th Anniversary in Hyatt Regency Washington on Capitol Hill (Washington DC, USA), with educational offerings from 30 September to 4 October 2010.
authors.affiliation: Center of Surgical and Molecular Tumor Pathology, National Institute of Oncology, Budapest, 1122 Rath Gy Street 7-9, Hungary. kotlanb@netscape.net
authors.forename: Beatrix
authors.initials: B
authors.lastname: Kotlan
authors.forename: James M
authors.initials: JM
authors.lastname: Balwit
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal